Focused Extracorporeal Shockwave Therapy for Knee Arthritis

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 13, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Bone Marrow EdemaKnee OsteoarthritisKnee Pain Chronic
Interventions
DEVICE

Focused extracorporeal shockwave therapy

High energy level shockwaves (between 0.28-0.60 mJ/mm\^2) will be focused over the subchondral bone with the bone marrow lesion, previously localized on MRI.

Trial Locations (2)

07927

RECRUITING

New Jersey Regenerative Institute, Cedar Knolls

07052

RECRUITING

Nathan Hogaboom, West Orange

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

New Jersey Regenerative Institute, LLC

INDUSTRY

lead

Kessler Foundation

OTHER

NCT05596591 - Focused Extracorporeal Shockwave Therapy for Knee Arthritis | Biotech Hunter | Biotech Hunter